Horyzons: Implementation and Integration in Clinical Practice
Key facts
- Who runs it
- University of North Carolina, Chapel Hill
- Where
- Chapel Hill, United StatesSee the site
- Trial code
- Status
- Terminated
- People taking part
- 52 people enrolled
- Started
- 8 Jan 2024
- Ended
- 31 Oct 2024
- Type of study
- Interventional, 2 groupsOne group gets no study treatment, for comparison.
- Treatments tested
- Horyzons USA
- Record updated
- 18 September 2025
- Why it stopped
- Reductions in available funding
Who can take part
- Age
- 16 years to 35 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
Show the full registry criteria (16)Hide the full registry criteria
Who can take part
- Clients must be between the ages of 16 and 35
- Clients must have a diagnosis of schizophrenia, schizoaffective disorder, schizophreniform disorder, or Unspecified Schizophrenia Spectrum or Other Psychotic disorder
- Clients must be receiving services at one of the five FEP clinics in North Carolina (OASIS, Encompass, Eagle, SHORE, or AEGIS) or one of their stepdown outpatient clinics (STEP and TIDES)
- Client not having any active thoughts of harming self in the month prior to enrollment
- Clients must not have been hospitalized for psychiatric reasons in the three months before enrollment
- Clients must actively be engaging with medication management through their clinic
- Clients must have access to the internet through a phone, tablet, or computer
- Provider \&/or PSS must be 18 years or older
- Provider \&/or PSS must be currently serving clients within their FEP clinic
- Provider \&/or PSS must be able to speak and read English
Who cannot take part
- Provider \&/or PSS under the age of 18
- Clients who do not speak English will not be considered for enrollment
- Adult client with legal guardians where one or both the individual and legal guardian do not provide consent for the individual to participate; PROVIDER PARTICIPANTS
- Provider \&/or PSS not currently serving clients in their FEP clinic
- Provider \&/or PSS not able to speak or understand English
Other criteria
- CLIENT PARTICIPANTS
Where in United States
- University of North Carolina at Chapel HillChapel Hill, United States
About the trial
What the trial wants to find out
The primary aim of this trial is evaluating the barriers and enablers of implementing a digital intervention with both therapeutic content and social networking, Horyzons, as part of clinical care in first episode psychosis (FEP) clinics in North Carolina. Providers (clinicians and peers support specialists) will be recruited from FEP clinics to assess Horyzons implementation and integration within clinical care at three time points (baseline, 6 months, and 12 months). Further, individuals experiencing FEP between the ages of 16 and 35 receiving services from the FEP clinics will be recruited to engage with the platform over the course of 12 months. Due to the nature of the digital intervention being implemented across the state of North Carolina, all research visits will be conducted remotely via videoconferencing.
The 2 groups in the trial
- FEP ProvidersNo study treatment, for comparison
Approximately 20 FEP providers (clinicians and peer support specialists) affiliated with first episode psychosis (FEP) clinics in North Carolina (OASIS, SHORE, Encompass, Eagle, AEGIS) will be recruited to share their perspectives of barriers and facilitators in implementing and integrating a digital intervention in clinical practice. They will be asked to complete a survey examining their perspective and beliefs at two time points (baseline, 9 months) as well as a qualitative interview based on the Consolidated Framework for Implementation Science at 9 months.
- FEP ClientsTreatment being tested
Approximately 50 individuals experiencing FEP and receiving services from FEP clinics (OASIS, SHORE, Encompass, Eagle, AEGIS) or their step down care clinics (STEP and TIDES) will be recruited to participate in a digital platform, Horyzons, for 12 months (for individuals enrolled at the initial opening of the platform; at a minimum 3 months of engagement) as part of their clinical care. Participants will have access to and encouraged to use the therapeutic content as well as the moderated online community network during their time engaging with the platform. They will be asked to complete a small battery of measures at baseline, 6-months, 12 months for individuals enrolled at the initiation of the study, while those enrolled later due to rolling recruitment may experience less assessment visits due to closing of the platform at the end of August 2024.
Treatment: Horyzons USA
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Record updated
- 18 September 2025